Encompass Health CORP Form 4 insider transactions

Director Nancy M. Schlichting acquired 39 restricted stock units as part of a dividend reinvestment program.

Director Terrance Williams acquired 27 restricted stock units in Encompass Health Corp via dividend reinvestment.

Encompass Health's Chief Accounting Officer, Andrew L. Price, disposed of 307 shares of common stock to cover tax obligations related to restricted stock vesting.

Encompass Health's Senior Vice President and Treasurer, Edmund Fay, disposed of 280 common shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Chief Medical Officer, Elissa Joy Charbonneau, disposed of 369 common shares to cover tax obligations related to restricted stock vesting.

Encompass Health's EVP, General Counsel & Secretary, John Patrick Darby, reported the acquisition of stock options and the disposition of shares for tax obligations.

Encompass Health Corp's President & CEO, Mark J. Tarr, reported the acquisition of stock options and the disposition of shares for tax obligations.

Encompass Health Corp's EVP and COO, Patrick W. Tuer, reported the acquisition of stock options and the disposition of shares for tax obligations.

Encompass Health's EVP & CFO, Douglas E. Coltharp, reported the disposition of shares for tax obligations and the acquisition of non-qualified stock options.

Encompass Health Corp's President and CEO, Mark J. Tarr, disposed of 2,488 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Sr. Vice President and Treasurer, Edmund Fay, disposed of 380 shares to cover tax obligations from restricted stock vesting.

Encompass Health's EVP and Chief Operating Officer, Patrick W. Tuer, executed a routine disposition of 506 common shares to satisfy tax obligations from restricted stock vesting.

Encompass Health's EVP & CFO, Douglas E. Coltharp, disposed of 14,818 common shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Chief Accounting Officer, Andrew L. Price, disposed of 404 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Chief Medical Officer, Elissa Joy Charbonneau, disposed of 440 shares of common stock to cover tax obligations related to restricted stock vesting.

Encompass Health Corp's EVP, General Counsel, and Secretary, John Patrick Darby, disposed of 6,990 shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Chief Medical Officer, Elissa Joy Charbonneau, reported the disposition of shares to cover tax obligations related to restricted stock vesting.

Encompass Health Corp's President & CEO, Mark J. Tarr, reported the withholding of shares to cover tax obligations related to restricted stock vesting.

Encompass Health Corp's Sr. Vice President and Treasurer, Edmund Fay, reported routine share disposals to cover tax obligations related to restricted stock vesting.

Encompass Health's Chief Accounting Officer, Andrew L. Price, filed a Form 4 detailing future stock dispositions to cover tax obligations from restricted stock vesting.

An Encompass Health Corp executive disposed of shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health Corp's EVP & CFO, Douglas E. Coltharp, reported the disposition of shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's Chief Operating Officer, Patrick W. Tuer, disposed of shares to cover tax withholding obligations from restricted stock vesting.

Encompass Health Corp's President and CEO, Mark J. Tarr, sold 140,000 shares of common stock on February 11, 2026, under a pre-arranged Rule 10b5-1 trading plan.

Encompass Health's EVP and Chief Operating Officer, Patrick William Tuer, reported a planned sale of 2,804 shares of common stock for February 10, 2026.

Encompass Health Director Cain A. Hayes received an award of 457 restricted stock units under the company's 2025 Omnibus Performance Incentive Plan.

Encompass Health Director Greg D. Carmichael acquired 28 shares of common stock through a routine restricted stock unit award tied to a dividend payment.

Encompass Health Corp. Director Joan E. Herman received 87 restricted stock units on January 15, 2026, as part of a routine dividend payment.

Encompass Health Director Leslye G. Katz received 87 restricted stock units as part of a dividend payment plan, increasing her direct beneficial ownership to 47,839 units.

Encompass Health Corp. Director Kevin J. O'Connor was awarded 17 restricted stock units on January 15, 2026, linked to a common stock dividend payment.